Eledon Pharmaceuticals, Inc. (ELDN) Operating cash flow 2016–2025
Eledon Pharmaceuticals, Inc. (ELDN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$62.3MFY2025 · since FY2016: -$4.9M → -$62.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$62.3M | -31.9% |
| FY2024 | -$47.3M | -19.6% |
| FY2023 | -$39.5M | -39.1% |
| FY2022 | -$28.4M | +1.7% |
| FY2021 | -$28.9M | -90.1% |
| FY2020 | -$15.2M | -9.8% |
| FY2019 | -$13.9M | -16.5% |
| FY2018 | -$11.9M | +20.4% |
| FY2017 | -$14.9M | -203.5% |
| FY2016 | -$4.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice